Can kids with arthritis safely reduce their medication?
NCT ID NCT07190053
Summary
This study aims to understand the best long-term treatment plans for children and teenagers with two specific types of juvenile arthritis (ERA and JPsA) who are taking the medication secukinumab. Researchers will use existing German patient registry data to track 100 young patients whose disease is under control. They want to see if treatment strategies like lowering the dose or taking breaks from the medication are effective at keeping the arthritis from flaring up again.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTHESITIS-RELATED ARTHRITIS (ERA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.